biomm: the ideal partner in biopharmaceuticals …...production using both animal and vegetable raw...
TRANSCRIPT
BIOMM: THE IDEAL PARTNER IN
BIOPHARMACEUTICALS PRODUCTION IN
BRAZIL
Following the entry of new
shareholders who supported the
Brazilian technological
development, BIOMM starts a
new and even stronger phase of
its successful history in 2014
with the construction of its new
insulin plant. Ultimately, the
outcome is the consolidation of
its outstanding expertise in the
recombinant cycle technology.
BIOMM HAS STRONG TIES WITH INSULIN PRODUCTION IN BRAZIL
1975 1979 1983 2000 2001
Establishment of Biobrás: Enzyme production using both animal and vegetable raw materials
Joint venture with North American Eli Lilly & Co: Production of insulin of animal origin in Brazil
Biobrás buys Eli Lilly’s share in the Joint Venture: Manufacture of highly purified insulin
First production patent for recombinant human insulin
Establishment of Biomm: Intellectual property, know-how, researchers and executives remain the same
WHAT MAKES BIOMM
THE BEST PARTNERIN BIOPHARMACEUTICALS IN BRAZIL?
Know-how, technology and patents in key global markets
Industrial plant already under construction
Experienced, specialized professionals
Private and Government
funds
BIOMMIDEAL PARTNER IN
BIOPHARMACEUTICALS PRODUCTION IN BRAZIL
First class team
GUILHERME EMRICH
Chairman of the Board
Internationally recognized biotech entrepreneur
FRANCISCO FREITAS
LUCIANO VILELA
HERALDO MARCHEZINI
Operations Director
30+ years of experience; responsible for the plant project
Technology Director
Expert in the R&D field; author of several BIOMM´s patents
CEO
25 years of experience in the industry, former Sanofi´s CEO
Executives with extensive experience and expertise are leading Biomm:
WHAT MAKES BIOMM THE IDEAL PARTNER IN BIOPHARMACEUTICALS PRODUCTION IN BRAZIL?
An old relation with insulin in both production and technology development, and a number of patents granted in demanding countries like USA, Germany and Israel
The company preserved the intellectual capital, know-how and R&D team that made Biobrás an outstanding case of success.
Innovation TrackRecord
WHAT MAKES BIOMM THE IDEAL PARTNER IN BIOPHARMACEUTICALS PRODUCTION IN BRAZIL?
20patents in key global markets Over
WHAT MAKES BIOMM THE IDEAL PARTNER IN BIOPHARMACEUTICALS PRODUCTION IN BRAZIL?
The factory is already a reality
One of the most modern biopharmaceutical plants in the world is already being built in Nova Lima, MG.
The new plant will have about 30 000 m² of floor area over a 100 000 m² land.
Structure
WHAT MAKES BIOMM THE IDEAL PARTNER IN BIOPHARMACEUTICALS PRODUCTION IN BRAZIL?
BIOMM´s Project is part of Brazilian government plan to enhance Brazil´s autonomy on key drugsInvestment required to build the plant already achieved: capitalization of approx. R$ 350 MM / USD 150 MM
All required construction licenses (environmental, implementation, etc...) already obtained
Plant construction started in July/14 at Nova Lima / MG
Long lead delivery equipment in final phase of acquisition
Job generation of 1.200 employees due to construction; 300 employees to run the plant
Structure
WHAT MAKES BIOMM THE IDEAL PARTNER IN BIOPHARMACEUTICALS PRODUCTION IN BRAZIL?
Dilma RousseffPresident of Brazil
Alexandre PadilhaMinistryof Health
AntonioAnastasia
FormerGovernor
of MG
Fernando PimentelMinistry of
Development,Industry and
Foreign Trade;Elected
Governor of MG
AloizioMercadanteChief of Staff
Walfrido Mares GuiaBIOMM Founder
Member of BIOMM´s BoardFormer Ministry
Announcement of BIOMM Project – April 2013
Marco Raupp
Ministry ofScience,
Technology and Innovation
LucianoCoutinhoPresdent of
BrazilianDevelopmentBank (BNDES)
Innovation Capital, by both private and public funds
The only player in the industry to be listed in the BOVESPA stock exchange (BIOM3)
Funding
WHAT MAKES BIOMM THE IDEAL PARTNER IN BIOPHARMACEUTICALS PRODUCTION IN BRAZIL?
Solid capital structure that allow multiple sources of additional resources
Funding
WHAT MAKES BIOMM THE IDEAL PARTNER IN BIOPHARMACEUTICALS PRODUCTION IN BRAZIL?
Biomm S.A.
Biomm
International, Inc
100%
TMG / MVA BNDES, Brazilian
Government
Development Bank
Free Float
22.0% 8.1% 14.0% 12.6%
BDMGTEC, State
Bank focused in
fostering innovation
Founding Partners
27.7%
* - Minor Shareholders: 15,6%
Know-how, technology and patents in key global markets
Industrial plant already under construction
Experienced and specialized professionals
Private and Government
funds
BIOMMIDEAL PARTNER IN
BIOPHARMACEUTICALS PRODUCTION IN BRAZIL
A SOLID REALITYA solid company, led by skilled professionals and investing heavily in one of the world’s most important industries